BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 14696905)

  • 1. Parental satisfaction with sumatriptan nasal spray in childhood migraine.
    Pakalnis A; Kring D; Paolicchi J
    J Child Neurol; 2003 Nov; 18(11):772-5. PubMed ID: 14696905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistency of response to sumatriptan nasal spray across patient subgroups and migraine types.
    Ashford E; Salonen R; Saiers J; Woessner M
    Cephalalgia; 1998 Jun; 18(5):273-7. PubMed ID: 9673807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of nasal sumatriptan in 5- to 12-year-old children.
    Hershey AD; Powers SW; LeCates S; Bentti AL
    Headache; 2001; 41(7):693-7. PubMed ID: 11554957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial.
    Ahonen K; Hämäläinen ML; Rantala H; Hoppu K
    Neurology; 2004 Mar; 62(6):883-7. PubMed ID: 15037686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
    Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M
    Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
    Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children.
    Callenbach PM; Pels LP; Mulder PG; Linssen WH; Gooskens RH; van der Zwan JL; Brouwer OF;
    Eur J Paediatr Neurol; 2007 Nov; 11(6):325-30. PubMed ID: 17428708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does sumatriptan nasal spray perform in clinical practice?
    Dahlöf CG; Boes-Hansen S; Cederberg CG; Hardebo JE; Henriksson A
    Cephalalgia; 1998 Jun; 18(5):278-82. PubMed ID: 9673808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations.
    Weidmann E; Unger J; Blair S; Friesen C; Hart C; Cady R
    Clin Ther; 2003 Jan; 25(1):235-46. PubMed ID: 12637123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
    Natarajan S; Jabbour JT; Webster CJ; Richardson MS
    Headache; 2004; 44(10):969-77. PubMed ID: 15546259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptans for treatment of acute pediatric migraine: a systematic literature review.
    Major PW; Grubisa HS; Thie NM
    Pediatr Neurol; 2003 Nov; 29(5):425-9. PubMed ID: 14684238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of new therapeutic deliveries in migraine.
    Dahlöf C
    Neurology; 2003 Oct; 61(8 Suppl 4):S31-4. PubMed ID: 14581656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Trial of Ketorolac vs. Sumatripan vs. Placebo Nasal Spray (KSPN) for Acute Migraine.
    Rao AS; Gelaye B; Kurth T; Dash PD; Nitchie H; Peterlin BL
    Headache; 2016 Feb; 56(2):331-40. PubMed ID: 26840902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study.
    Rothner AD; Winner P; Nett R; Asgharnejad M; Laurenza A; Austin R; Peykamian M
    Clin Ther; 2000 Dec; 22(12):1533-46. PubMed ID: 11192144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute cluster headache with 20 mg sumatriptan nasal spray--an open pilot study.
    Schuh-Hofer S; Reuter U; Kinze S; Einhäupl KM; Arnold G
    J Neurol; 2002 Jan; 249(1):94-9. PubMed ID: 11954875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan nasal spray for migraine: a review of studies in patients aged 17 years and younger.
    Hämäläinen M; Jones M; Loftus J; Saiers J
    Int J Clin Pract; 2002 Nov; 56(9):704-9. PubMed ID: 12469987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine.
    Touchon J; Bertin L; Pilgrim AJ; Ashford E; Bès A
    Neurology; 1996 Aug; 47(2):361-5. PubMed ID: 8757005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies.
    Dahlöf C
    Cephalalgia; 1999 Nov; 19(9):769-78. PubMed ID: 10595285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.